Document:

EX-10.1

 Exhibit 10.1 

PREMIER, INC. 
 2013 EQUITY
INCENTIVE PLAN 
 (as amended and restated effective December 7, 2018) 

 

	1.	 Establishment, Purpose and Duration. Premier, Inc. (referred to below as the “Company”)
established the Premier, Inc. 2013 Equity Incentive Plan, which became effective upon approval by the Company’s stockholders on September 24, 2013. The 2013 Equity Incentive Plan was amended and restated upon approval of the Company’s
stockholders at the annual meeting of stockholders on December 4, 2015, and an increased compensation limit for Non-Employee Directors was approved by the Company’s stockholders at the annual meeting
of the Company’s stockholders on December 1, 2017. The 2013 Equity Incentive Plan is hereby being further amended and restated, subject to and effective upon the approval of the Company’s stockholders at the annual meeting of
stockholders on December 7, 2018 (hereinafter referred to below as the “Plan”). The purpose of the Plan is to attract and retain Employees, Non-Employee Directors, and Consultants and to provide
additional incentives for these persons consistent with the long-term success of the Company’s business. Unless sooner terminated as provided herein, the Plan shall terminate on September 24, 2023. After the Plan is terminated, no further
Awards may be granted but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and the Plan’s terms and conditions. 

 

	2.	 Definitions. As used in the Plan, the following terms shall be defined as set forth below:

  

	 	2.1	 “Act” means the Securities Exchange Act of 1934, as amended. 

 

	 	2.2	 “Affiliate” means any corporation or any other entity (including, but not limited to, a
partnership) that is affiliated with the Company through equity ownership or otherwise. 

  

	 	2.3	 “Award” or “Awards” means, individually or collectively, except
where referring to a particular category of grant under the Plan, a grant under the Plan of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Shares, Restricted Stock Units, Performance Share Awards,
Cash-Based Awards, or Other Stock-Based Awards, in each case subject to the terms of the Plan. Grandfathered Awards may, as determined by the Committee in its discretion, constitute Performance-Based Awards. 

 

	 	2.4	 “Award Agreement” means an agreement, certificate, resolution or other form of writing
or other evidence approved by the Committee which sets forth the terms and conditions of an Award. An Award Agreement may be in an electronic medium, may be limited to a notation on the Company’s books and records and, if approved by the
Committee, need not be signed by a representative of the Company or a Participant. 

	 	2.5	 “Base Price” means the price to be used as the basis for determining the Spread upon
the exercise of a Stock Appreciation Right. 

  

	 	2.6	 “Beneficial Owner” shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Act. 

  

	 	2.7	 “Board” means the Board of Directors of the Company. 

 

	 	2.8	 “Cash-Based Award” means an Award granted to a Participant as described in
Section 11. 

  

	 	2.9	 “Change in Control” shall have the meaning given to it in Section 13.3.

  

	 	2.10	 “Code” means the Internal Revenue Code of 1986, as amended from time to time.

  

	 	2.11	 “Committee” means the Compensation Committee of the Board described in Section 4.

  

	 	2.12	 “Company” means Premier, Inc. or its successor. 

 

	 	2.13	 “Consultant” means any natural person, including an advisor, engaged by the Company or
any Affiliate to render bona fide services to such entity (other than in connection with the offer or sale of securities in a capital-raising transaction or to promote or maintain a market for the Company’s securities). 

 

	 	2.14	 “Deferred Stock Unit” means an Award that is vested on the Grant Date that entitles the
recipient to receive Shares after a designated period of time. Deferred Stock Units shall be subject to such restrictions and conditions as set forth in the Award Agreement, which shall be consistent with the provisions for Restricted Stock Units
set forth in Section 8 below except for the requirement to have a Restricted Period or Performance Goals. 

  

	 	2.15	 “Employee” means any person designated as an employee of the Company, any of its
Affiliates, and/or any of its or their Subsidiaries on the payroll records thereof. 

  

	 	2.16	 “Executive Officer” means an “executive officer” of the Company as defined by
Rule 3b-7 under the Act. To the extent that the Board takes action to designate the persons who are the “executive officers” of the Company, the persons so designated (and no others) shall be deemed
to be the “executive officers” of the Company for all purposes of the Plan. 

	 	2.17	 “Fair Market Value” means a price that is based on the opening, closing, actual, high,
low, or average selling prices of a Share reported on the NASDAQ Global Select Market or other established stock exchange (or exchanges) on the applicable date, the preceding trading day, the next succeeding trading day, an average of trading days
or on any other basis consistent with the requirements of the stock rights exemption under Section 409A of the Code using actual transactions involving Shares, as determined by the Committee in its discretion. In the event Shares are not
publicly traded at the time a determination of their value is required to be made hereunder, the determination of their Fair Market Value shall be made by the Committee in such manner as it deems appropriate. Such definition(s) of Fair Market Value
shall be specified in each Award Agreement and may differ depending on whether Fair Market Value is in reference to the grant, exercise, vesting, settlement, or payout of an Award; provided, however, that upon a broker-assisted exercise of an
Option, the Fair Market Value shall be the price at which the Shares are sold by the broker. 

  

	 	2.18	 “Family Member” means a Participant’s spouse, parents, children and grandchildren.

  

	 	2.19	 “Full Value Award” means an Award other than an Option or a Stock
Appreciation Right. 

  

	 	2.20	 “Grandfathered Award” shall have the meaning given to it in Section 14.1 below.

  

	 	2.21	 “Grant Date” means the date specified by the Committee on which a grant of an Award
shall become effective, which shall not be earlier than the date on which the Committee takes action with respect thereto. 

  

	 	2.22	 “Incentive Stock Option” means any Option that is intended to qualify as an
“incentive stock option” under Section 422 of the Code or any successor provision. 

  

	 	2.23	 “Non-Employee Director” means a member of the Board who is
not an Employee. 

  

	 	2.24	 “Nonqualified Stock Option” means an Option that is not intended to qualify as an
Incentive Stock Option. 

  

	 	2.25	 “Option” means any option to purchase Shares granted under Section 5.

  

	 	2.26	 “Option Price” means the purchase price payable upon the exercise of an Option.

	 	2.27	 “Other Stock-Based Award” means an equity-based or equity-related Award not otherwise
described by the terms of this Plan granted under Section 10. 

  

	 	2.28	 “Participant” means an Employee, Non-Employee
Director or a Consultant who is selected by the Committee to receive benefits under the Plan, provided that only Employees shall be eligible to receive grants of Incentive Stock Options. 

 

	 	2.29	 “Performance-Based Award” means an Award described in
Section 14 below. 

  

	 	2.30	 “Performance Criteria” means the criteria that the Committee selects for purposes of
establishing the Performance Goal or Performance Goals for a Participant with respect to the Performance Cycle. The Performance Criteria may be described in terms of Company-wide objectives or objectives that are related to the performance of the
individual Participant or an organizational level specified by the Committee, including, but not limited to, a Subsidiary or Affiliate or a unit, division or group of the Company, a Subsidiary or Affiliate. Performance Criteria may be measured on an
absolute or relative basis, including but not limited to performance as measured against a group of peer companies or by a financial market index. 

  

	 	2.31	 “Performance Cycle” means one or more periods of time, which may be of varying and
overlapping durations, as the Committee may select, over which the attainment of one or more Performance Criteria will be measured for the purpose of determining a grantee’s right to and the payment of a Restricted Share Award, Restricted Stock
Unit, Performance Share Award, Other Stock-Based Award or Cash-Based Award. 

  

	 	2.32	 “Performance Goals” means, with respect to a Restricted Share Award, a Restricted Stock
Unit Award, a Performance Share Award or a Cash-Based Award, the specific goal or goals established in writing by the Committee for the Performance Cycle applicable to such Award. 

 

	 	2.33	 “Performance Share Award” means an Award denominated in either Shares or share units
granted pursuant to Section 9. 

  

	 	2.34	 “Plan” shall have the meaning set forth in Section 1 above. 

 

	 	2.35	 “Restricted Period” means a period of time established under Section 8 with
respect to Restricted Stock Units. 

  

	 	2.36	 “Restricted Shares” means Shares granted under Section 7 subject to a substantial
risk of forfeiture. 

	 	2.37	 “Restricted Stock Units” means an Award pursuant to Section 8 of the right to
receive Shares at the end of a specified period. 

  

	 	2.38	 “SEC” means the U.S. Securities and Exchange Commission. 

 

	 	2.39	 “Share Authorization” means the maximum number of Shares available for grant under the
Plan, as described in Section 3. 

  

	 	2.40	 “Shares” means the Class A common stock of the Company. 

 

	 	2.41	 “Spread” means, in the case of a Stock Appreciation Right, the amount by which the Fair
Market Value on the date when any such right is exercised exceeds the Base Price specified in such right. 

  

	 	2.42	 “Stock Appreciation Right” means a right granted under Section 6.

  

	 	2.43	 “Subsidiary” means any corporation or other entity, whether domestic or foreign, in
which the Company has or obtains, directly or indirectly, a proprietary interest of more than twenty percent (20%) by reason of stock ownership or otherwise. 

  

	 	2.44	 “Substitute Award” means any Award granted or issued to a Participant in assumption or
substitution of either outstanding awards or the right or obligation to make future awards by an entity acquired by the Company, an Affiliate or a Subsidiary or with which the Company, an Affiliate or a Subsidiary combines. 

 

	 	2.45	 “Unrestricted Shares” means a grant of Shares free of any Restricted Period,
Performance Goals or any substantial risk of forfeiture. Unrestricted Shares may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to an Employee. 

 

	3.	 Shares Available Under the Plan. 

 

	 	3.1	 Number of Shares Reserved for Awards. 

 

	 	(a)	 Subject to adjustments as provided in Section 12 and the additional limits applicable to Non-Employee Directors set forth in Section 3.1(b) below, the Share Authorization shall be 14,760,783 Shares of which: 

  

	 	i.	 no more than 14,760,783 Shares shall be eligible to be issued as Incentive Stock Options,

  

	 	ii.	 grants of Options and Stock Appreciation Rights with respect to no more than 500,000 Shares may be made to any
single Participant during a single calendar year, 

	 	iii.	 no more than 500,000 Shares may be subject to Full Value Awards granted to any single Participant during a
single calendar year or in the event such Full Value Award is paid in cash, other securities or other property, no more than the Fair Market Value of 500,000 Full Value Shares on the date such Award vests or is no longer subject to risk of
forfeiture, and 

  

	 	iv.	 the maximum amount that can be paid to any single Participant pursuant to a Cash-Based Award described in
Section 11 of the Plan with respect to (A) a Performance Cycle that is 12 months or less shall be $3,000,000 and (B) a Performance Cycle that is more than 12 months shall be $6,000,000. 

 

	 	(b)	 The aggregate value of Awards granted to, and cash compensation earned by, a
Non-Employee Director during a single calendar year shall not exceed $500,000 For purposes of applying the limit under this Section 3.1(b), (A) the value of an Award other than an Option or Stock
Appreciation Right shall be the Fair Market Value of a Share on the Award’s Grant Date and (B) the value of an Option or Stock Appreciation Right shall be equal to fair value of such Award using (i) the Black-Scholes option pricing
model or other option pricing model as may be used by the Company from time to time to report its financial results and (ii) the option expensing assumptions as set forth in the Company’s most recent prior Form 10-K filing with the SEC or, if closer in time to the applicable Grant Date, the Company’s most recent prior Form 10-Q filing with the SEC, as reasonably determined by
the Committee. 

  

	 	(c)	 No Award granted under the Plan may provide for vesting before the first (1st) anniversary of the Grant Date. In addition, no Award granted to an Employee may provide for vesting which is more rapid than annual pro rata vesting over a three (3) year period and any Award
granted to an Employee which vests upon the attainment of Performance Goals shall provide for a Performance Cycle of at least twelve (12) months. Notwithstanding the foregoing, the Committee may provide for or permit acceleration of vesting of
such Awards in the event of a Change in Control or the Participant’s death, disability, or other qualifying termination of service as determined by the Committee. 

 

	 	3.2	 Share Usage. 

 

	 	(a)	 Any Shares related to Awards that terminate by expiration, forfeiture, cancellation, or otherwise without the
issuance of such Shares, are settled in cash in lieu of Shares, or are exchanged with the Committee’s permission, prior to the issuance of Shares, for Awards not involving Shares, shall be available again for grant under the Plan. In addition,
Restricted Shares that are forfeited shall again be available for grant under the Plan. 

	 	(b)	 Awards that are to be settled by the issuance of Shares shall only be counted against the Share Authorization
to the extent Shares are actually issued upon settling the Award. Any Shares withheld to satisfy tax withholding obligations on an Award, Shares tendered to pay the exercise price of an Option under the Plan and Shares repurchased on the open market
with the proceeds of an Option exercise shall again be available for grant under the Plan. 

  

	 	(c)	 Substitute Awards shall not be counted against the Shares available for granting Awards under the Plan.

  

	4.	 Plan Administration. 

 

	 	4.1	 Board Committee Administration. The Plan shall be administered by the Compensation Committee
appointed by the Board from among its members, provided that the full Board may at any time act as the Committee. The interpretation and construction by the Committee of any provision of the Plan or of any Award Agreement and any determination by
the Committee pursuant to any provision of the Plan or any such agreement, notification or document shall be final and conclusive. No member of the Committee shall be liable to any person for any such action taken or determination made in good
faith. 

  

	 	4.2	 Terms and Conditions of Awards. The Committee shall have final discretion, responsibility, and
authority to: 

  

	 	(a)	 grant Awards; 

  

	 	(b)	 determine the Participants to whom and the times at which Awards shall be granted; 

 

	 	(c)	 determine the type and number of Awards to be granted, the number of Shares to which an Award may relate, and
the applicable terms, conditions, and restrictions, including the length of time for which any restriction shall remain in effect; 

  

	 	(d)	 establish and administer Performance Goals and Performance Cycles relating to any Award; 

 

	 	(e)	 determine the rights of Participants with respect to an Award upon termination of employment or service as a
director; 

	 	(f)	 determine whether, to what extent, and under what circumstances an Award may be settled, cancelled, forfeited,
exchanged, or surrendered; 

  

	 	(g)	 accelerate the vesting of an Award; 

 

	 	(h)	 interpret the terms and provisions of Award Agreements; 

 

	 	(i)	 provide for forfeiture of outstanding Awards and recapture of realized gains and other realized value in such
events as determined by the Committee; and 

  

	 	(j)	 make all other determinations deemed necessary or advisable for the administration of the Plan.

 The Committee may solicit recommendations from the Company’s Chief Executive Officer with respect to the grant of
Awards under the Plan. The Committee (or, as permitted under Section 4.3, the Company’s Chief Executive Officer) shall determine the terms and conditions of each Award at the time of grant. No Participant or any other person shall have any
claim to be granted an Award under the Plan at any time, and the Company is not obligated to extend uniform treatment to Participants under the Plan. The terms and conditions of Awards need not be the same with respect to each Participant. 

 

	 	4.3	 Committee Delegation. The Committee may delegate to the Company’s Chief Executive Officer
the authority to grant Awards to Participants who are not Non-Employee Directors or Executive Officers and to interpret and administer Awards for such Participants. Any such delegation shall be subject to the
limitations of Section 157(c) of the Delaware General Corporation Law. The Committee may also delegate the authority to grant Awards to any subcommittee(s) consisting of members of the Board. 

 

	 	4.4	 Awards to Non-Employee Directors. Notwithstanding any other provision
of the Plan to the contrary, all Awards to Non-Employee Directors must be authorized by the Board. 

  

	 	4.5	 Employee’s Service as
Non-Employee Director or Consultant. An Employee who receives an Award, terminates employment, and immediately thereafter begins performing service as a
Non-Employee Director or Consultant shall have such service treated as service as an Employee for purposes of the Award. The previous sentence shall not apply when (a) the Award is an Incentive Stock
Option or (b) prohibited by law. 

	5.	 Options. The Committee may authorize grants to Participants of Options to purchase Shares upon
such terms and conditions as the Committee may determine in accordance with the following provisions: 

  

	 	5.1	 Number of Shares. Each grant shall specify the number of Shares to which it pertains.

  

	 	5.2	 Option Price. Each grant shall specify an Option Price per Share, which shall be equal to or
greater than the Fair Market Value per Share on the Grant Date, except in the case of Substitute Awards or as provided in Section 12. 

  

	 	5.3	 Consideration. Each grant shall specify the form of consideration to be paid in satisfaction of
the Option Price and the manner of payment of such consideration, which may include in the Committee’s sole discretion: (a) cash in the form of currency or check or other cash equivalent acceptable to the Company, (b) nonforfeitable,
unrestricted Shares owned by the Participant which have a value at the time of exercise that is equal to the Option Price, (c) a reduction in Shares issuable upon exercise which have a value at the time of exercise that is equal to the Option
Price (a “net exercise”), (d) to the extent permitted by applicable law, the proceeds of sale from a broker-assisted cashless exercise, (e) any other legal consideration that the Committee may deem appropriate on such basis as the
Committee may determine in accordance with the Plan or (f) any combination of the foregoing. For the avoidance of doubt, Participants who receive Options to purchase Shares shall have no legal right to own or receive Shares withheld from
delivery upon exercise pursuant to Section 5.3(c), and otherwise shall have no rights in respect of such Shares whether as a shareholder or otherwise. 

  

	 	5.4	 Vesting. Any grant may specify (a) a waiting period or periods before Options shall become
exercisable and (b) permissible dates or periods on or during which Options shall be exercisable, and any grant may provide for the earlier exercise of such rights in the event of a termination of employment. Vesting may be further conditioned
upon the attainment of Performance Goals established by the Committee. 

  

	 	5.5	 Provisions Governing ISOs. Options granted under the Plan may be Incentive Stock Options,
Nonqualified Stock Options or a combination of the foregoing, provided that only Nonqualified Stock Options may be granted to Non-Employee Directors. Each grant shall specify whether (or the extent to which)
the Option is an Incentive Stock Option or a Nonqualified Stock Option. Notwithstanding any such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Options designated as Incentive Stock Options are
exercisable for the first time by an Participant during any calendar year (under all plans of the Company) exceeds $100,000, such Options shall be treated as Nonqualified Stock Options. Options failing to qualify as Incentive Stock Options for any
reason will be treated as Nonqualified Stock Options, rather than being forfeited. 

	 	5.6	 Exercise Period. 

 

	 	(a)	 Subject to Section 18.9, no Option granted under the Plan may be exercised more than ten years from the
Grant Date. 

  

	 	(b)	 The Committee may, in its sole discretion, implement a provision in existing and future grants of Options
providing that if, on the last day that an Option may be exercised, the Participant has not then exercised such Option, such Option shall be deemed to have been exercised by the Participant on such last day and the Company shall make the appropriate
payment to such Participant after applying minimum required tax withholding. The Committee may delegate this authority to one or more of the Company’s officers, who may implement this provision by including it in Award Agreements or including
it in the Plan’s administrative rules, provided that such officers may not implement such exercise in Options issued to Non-Employee Directors or Executive Officers. 

 

	 	5.7	 Award Agreement. Each grant shall be evidenced by an Award Agreement containing such terms and
provisions as the Committee may determine consistent with the Plan. 

  

	 	5.8	 Options — Stock Rights Exemption. Options granted under the Plan are intended to qualify as
“stock rights” within the meaning of Treas. Reg. Section 1.409A-1(b)(5). 

  

	6.	 Stock Appreciation Rights. The Committee may authorize grants to Participants of Stock
Appreciation Rights. A Stock Appreciation Right is the right of the Participant to receive from the Company an amount, which shall be determined by the Committee and shall be expressed as a percentage (not exceeding 100 percent) of the Spread at the
time of the exercise of such right. Any grant of Stock Appreciation Rights under the Plan shall be upon such terms and conditions as the Committee may determine in accordance with the following provisions: 

 

	 	6.1	 Payment in Cash or Shares. Any grant may specify that the amount payable upon the exercise of a
Stock Appreciation Right will be paid by the Company in cash, Shares or any combination thereof or may grant to the Participant or reserve to the Committee the right to elect among those alternatives. 

 

	 	6.2	 Vesting. Any grant may specify (a) a waiting period or periods before Stock Appreciation
Rights shall become exercisable and (b) permissible dates or periods on or during which Stock Appreciation Rights shall be exercisable, and any grant may provide for the earlier exercise of such rights in the event of a termination of
employment. Vesting may be further conditioned upon the attainment of Performance Goals established by the Committee. 

	 	6.3	 Exercise Period. Subject to Section 18.9, no Stock Appreciation Right granted under the Plan
may be exercised more than ten years from the Grant Date. The Committee may impose deemed exercise rules on Stock Appreciation Rights on substantially the same terms and conditions as permitted for Options under Section 5.6(b) above.

  

	 	6.4	 Award Agreement. Each grant shall be evidenced by an Award Agreement containing such terms and
provisions as the Committee may determine consistent with the Plan. 

  

	 	6.5	 Stock Appreciation Rights — Stock Rights Exemption. Stock Appreciation Rights granted under
the Plan are intended to qualify as “stock rights” within the meaning of Treas. Reg. Section 1.409A-1(b)(5). 

 

	7.	 Restricted Shares. The Committee may authorize grants to Participants of Restricted Shares upon
such terms and conditions as the Committee may determine in accordance with the following provisions: 

  

	 	7.1	 Transfer of Shares. Each grant shall constitute an immediate transfer of the ownership of Shares
to the Participant in consideration of the performance of services, subject to the substantial risk of forfeiture and restrictions on transfer hereinafter referred to. 

 

	 	7.2	 Consideration. To the extent permitted by Delaware law, each grant may be made without additional
consideration from the Participant or in consideration of a payment by the Participant that is less than the Fair Market Value on the Grant Date. 

  

	 	7.3	 Substantial Risk of Forfeiture. Each grant shall provide that the Restricted Shares covered
thereby shall be subject to a “substantial risk of forfeiture” within the meaning of Section 83 of the Code for a period to be determined by the Committee on the Grant Date, and any grant or sale may provide for the earlier
termination of such risk of forfeiture in the event of a termination of employment. 

  

	 	7.4	 Dividend, Voting and Other Ownership Rights. Unless otherwise determined by the Committee, an
award of Restricted Shares shall entitle the Participant to dividend, voting and other ownership rights (except for any rights to a liquidating distribution) during the period for which such substantial risk of forfeiture is to continue. Any grant
shall require that any or all dividends or other distributions paid on the Restricted Shares during the period of such restrictions be accumulated or reinvested in additional Shares, which shall be subject to the same restrictions as the underlying
Award or such other restrictions as the Committee may determine. 

	 	7.5	 Restrictions on Transfer. Each grant shall provide that, during the period for which such
substantial risk of forfeiture is to continue, the transferability of the Restricted Shares shall be prohibited or restricted in the manner and to the extent prescribed by the Committee on the Grant Date. 

 

	 	7.6	 Performance-Based Restricted Shares. Any grant or the vesting thereof may be further conditioned
upon the attainment of Performance Goals established by the Committee in accordance with the applicable provisions of Section 9 regarding Performance Share Awards. 

 

	 	7.7	 Award Agreement; Certificates. Each grant shall be evidenced by an Award Agreement containing
such terms and provisions as the Committee may determine consistent with the Plan. Unless otherwise directed by the Committee, all certificates representing Restricted Shares, together with a stock power that shall be endorsed in blank by the
Participant with respect to such Shares, shall be held in custody by the Company until all restrictions thereon lapse. 

  

	8.	 Restricted Stock Units. The Committee may authorize grants of Restricted Stock Units to
Participants upon such terms and conditions as the Committee may determine in accordance with the following provisions: 

  

	 	8.1	 Restricted Period. Each grant shall provide that the Restricted Stock Units covered thereby shall
be subject to a Restricted Period, which shall be fixed by the Committee on the Grant Date, and any grant or sale may provide for the earlier termination of such period in the event of a termination of employment. 

 

	 	8.2	 Dividend Equivalents and Other Ownership Rights. During the Restricted Period, the Participant
shall not have any right to transfer any rights under the subject Award and shall not have any rights of ownership in the Shares underlying the Restricted Stock Units, including the right to vote such Shares, but the Committee may on or after the
Grant Date authorize the award of dividend equivalents on such shares with respect to any or all dividends or other distributions paid by the Company. A dividend equivalent will entitle the Participant to receive amounts equal to all or any portion
of the dividends or other distributions that would be paid on the Shares covered by such Award if such Shares had been delivered pursuant to such Award (without interest). The Participant receiving the dividend equivalent will have only the rights
of a general unsecured creditor of the Company until payment of such amounts is made. Notwithstanding the foregoing, any dividend equivalents shall be subject to the same restrictions as the underlying Award. In no event may cash dividends be paid
on Restricted Stock Units during the Restricted Period. 

	 	8.3	 Performance-Based Restricted Share Units. Any grant or the vesting thereof may be further
conditioned upon the attainment of Performance Goals established by the Committee in accordance with the applicable provisions of Section 9 regarding Performance Share Awards. 

 

	 	8.4	 Award Agreement. Each grant shall be evidenced by an Award Agreement containing such terms and
provisions as the Committee may determine consistent with the Plan. 

  

	9.	 Performance Share Awards. The Committee shall determine whether and to whom Performance Share
Awards shall be granted and such terms, limitations and conditions as it deems appropriate in its sole discretion in accordance with the following provisions: 

 

	 	9.1	 Number of Performance Share Awards. Each grant shall specify the number of Shares or share units
to which it pertains, which may be subject to adjustment to reflect changes in compensation or other factors. 

  

	 	9.2	 Performance Cycle. The Performance Cycle with respect to each Performance Share Award shall be
determined by the Committee and set forth in the Award Agreement and may be subject to earlier termination in the event of a termination of employment. 

  

	 	9.3	 Performance Goals. Each grant shall specify the Performance Goals that are to be achieved by the
Participant and a formula for determining the amount of any payment to be made if the Performance Goals are achieved. 

  

	 	9.4	 Payment of Performance Share Awards. Each grant shall specify the time and manner of payment of
Performance Share Awards that shall have been earned. 

  

	 	9.5	 Dividend Equivalents. Under no circumstances may dividend equivalents be granted for any
Performance Share Award. 

  

	 	9.6	 Adjustments. If the Committee determines after the Performance Goals have been established that a
change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances render the Performance Goals unsuitable, the Committee shall have sole
discretion to modify such Performance Goals, in whole or in part, as the Committee deems appropriate and equitable. The Committee shall also have the right in its sole discretion to increase or decrease the amount payable at a given level of
performance to 

	 	
take into account additional factors that the Committee may deem relevant to the assessment of individual or corporate performance for the Performance Cycle. The provisions of this
Section 9.6 shall not apply with respect to Performance-Based Awards and any modifications with respect to such Awards shall be made solely to the extent permitted under Section 14.2. 

 

	 	9.7	 Award Agreement. Each grant shall be evidenced by an Award Agreement containing such terms and
provisions as the Committee may determine consistent with the Plan. 

  

	10.	 Other Equity Awards. The Committee may grant other types of equity-based or equity-related Awards
not otherwise described by the terms of the Plan (including the grant or offer for sale of unrestricted Shares and grant of Deferred Stock Units) in such amounts and subject to such terms and conditions, as the Committee shall determine. Such Awards
may involve the transfer of actual Shares to Participants, or payment in cash or otherwise of amounts based on the value of Shares and may include, without limitation, Awards designed to comply with or take advantage of the applicable local laws of
jurisdictions other than the United States. 

  

	11.	 Cash-Based Awards. The Committee may, in its sole discretion, grant Cash-Based Awards to
Executive Officers and key employees in such amounts and upon such terms, and subject to such conditions, as the Committee shall determine at the time of grant. The Committee shall determine the maximum duration of the Cash-Based Award, the amount
of cash to which the Cash-Based Award pertains, the conditions upon which the Cash-Based Award shall become vested or payable, and such other provisions as the Committee shall determine. Each Cash-Based Award shall specify a cash-denominated payment
amount, formula or payment ranges as determined by the Committee. Payment, if any, with respect to a Cash-Based Award shall be made in accordance with the terms of the Award and shall be made in cash. 

 

	12.	 Adjustments. The Committee shall make or provide for such adjustments in the (a) limitations
specified in Section 3, (b) number of Shares covered by outstanding Awards, (c) Option Price or Base Price applicable to outstanding Options and Stock Appreciation Rights and (d) kind of shares available for grant and covered by
outstanding Awards (including shares of another issuer), as the Committee in its sole discretion may in good faith determine to be equitably required in order to prevent dilution or enlargement of the rights of Participants that otherwise would
result from (x) any stock dividend, stock split, reverse stock split, combination or exchange of Shares, recapitalization, extraordinary cash dividend, or other change in the capital structure of the Company, (y) any merger, consolidation,
spin-off, spin-out, split-off, split-up, reorganization, partial or complete liquidation
or other distribution of assets (other than a normal cash dividend), issuance of rights or warrants to purchase securities or (z) any other corporate transaction or event having an effect similar to any of the foregoing. In addition, in the
event of any such transaction or event, the 

	 	
Committee may provide in substitution for any or all outstanding Awards under the Plan such alternative consideration as it may in good faith determine to be equitable under the circumstances and
may require in connection therewith the cancellation or surrender of all Awards so replaced. In the case of Substitute Awards, the Committee may make such adjustments, not inconsistent with the terms of the Plan, in the terms of Awards as it shall
deem appropriate in order to achieve reasonable comparability or other equitable relationship between the assumed awards and the Awards granted under the Plan as so adjusted. 

 

	13.	 Change in Control. 

 

	 	13.1	 General Rule. Except as otherwise provided in an Award Agreement, in the event of a Change in
Control, the Committee may, but shall not be obligated to do any one or more of the following, in each case without Participant consent: (a) accelerate, vest or cause the restrictions to lapse with respect to, all or any portion of an Award,
(b) cancel Awards for a cash payment equal to their fair value (as determined in the sole discretion of the Committee) which, in the case of Options and Stock Appreciation Rights, shall be deemed to be equal to the excess, if any, of the
consideration to be paid in connection with the Change in Control to holders of the same number of Shares subject to such Options or Stock Appreciation Rights (or, if no consideration is paid in any such transaction, the Fair Market Value of the
Shares subject to such Options or Stock Appreciation Rights) over the aggregate Option Price (in the case of Options) or Base Price (in the case of Stock Appreciation Rights), (c) provide for the issuance of replacement awards that will
substantially preserve the otherwise applicable terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion, (d) terminate Options without providing accelerated vesting or (e) take any
other action with respect to the Awards the Committee deems appropriate. For avoidance of doubt, the treatment of Awards upon a Change in Control may vary among Participants and Types of Awards in the Committee’s sole discretion.

  

	 	13.2	 Settlement of Awards Subject to Performance Goals Upon a Change in Control. Awards subject to
satisfying a Performance Goal or Goals shall be settled upon a Change in Control. The settlement amount shall be determined by the Committee in its sole discretion based upon the extent to which the Performance Goals for any such Awards have been
achieved after evaluating actual performance from the start of the Performance Cycle until the date of the Change in Control and the level of performance anticipated with respect to such Performance Goals as of the date of the Change in Control.

	 	13.3	 Change in Control shall mean the earliest to occur of the following events, provided that such
event is not also a Management Buyout (as defined below): 

  

	 	(a)	 Any Person (as defined below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the
Company representing 35% or more of the combined voting power of the Company’s then outstanding voting securities generally entitled to vote in the election of directors of the Company, provided, however, that for avoidance of doubt, the
shareholders owning the Company’s Class B common stock shall be treated as the Beneficial Owner with voting control for purposes of this definition, and not any Persons voting the shares subject to a voting trust or other similar
arrangement, and further provided that no Change in Control will be deemed to have occurred as a result of a change in ownership percentage resulting solely from an acquisition of securities by the Company or a transaction described in clause
(i) of paragraph (b) below; 

  

	 	(b)	 There is consummated a Merger of the Company with any other business entity other than (i) a Merger which
would result in the securities of the Company generally entitled to vote in the election of directors of the Company outstanding immediately prior to such Merger continuing to represent (either by remaining outstanding or by being converted into
such securities of the surviving entity or any parent thereof), in combination with the ownership of any trustee or other fiduciary holding such securities under an employee benefit plan of the Company or any Subsidiary at least 50% of the combined
voting power of the voting securities of the Company or such surviving entity or any parent thereof outstanding immediately after such Merger, generally entitled to vote in the election of directors of the Company or such surviving entity or any
parent thereof and, in the case of such surviving entity or any parent thereof, of a class registered under Section 12 of the Act, or (ii) a Merger effected to implement a recapitalization of the Company (or similar transaction) in which
no Person is or becomes a Beneficial Owner, directly or indirectly, of securities of the Company’s then outstanding voting securities of the Company generally entitled to vote in the election of directors of the Company; 

 

	 	(c)	 The stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or there
is consummated the sale or disposition by the Company of all or substantially all of the Company’s assets, other than a sale or disposition by the Company of all or substantially all of the Company’s assets to an entity where the
outstanding securities generally entitled to vote in the election of directors of the Company immediately prior to the transaction continue to represent (either by remaining outstanding or by being converted into such securities of the surviving
entity or any parent thereof) 50% or more of the combined voting power of the outstanding voting securities of any such entity generally entitled to vote in such entity’s election of directors immediately after such sale and of a class
registered under Section 12 of the Act. 

	 	(d)	 As used in this Section 13: 

 

	 	i.	 “Management Buyout” means any event or transaction which would otherwise constitute a Change in
Control (a “Transaction”) if, in connection with the Transaction, the Participant, Family Members and/or the Participant’s Affiliates participate, directly or beneficially, as an equity investor in, or have the option or right to
acquire, whether vested or not vested, equity interests of, the acquiring entity or any of its Affiliates (as defined in Rule 12b-2 under the Act) (the “Acquiror”) having a percentage interest
therein greater than 1%. For purposes of the preceding sentence, a party shall not be deemed to have participated as an equity investor in the Acquiror by virtue of (i) obtaining Beneficial Ownership of any equity interest in the Acquiror as a
result of the grant to the party of an incentive compensation award under one or more incentive plans of the Acquiror (including, but not limited to, the conversion in connection with the Transaction of incentive compensation awards of the Company
into incentive compensation awards of the Acquiror), on terms and conditions substantially equivalent to those applicable to other employees of the Company at a comparable level as such party immediately before the Transaction, after taking into
account normal differences attributable to job responsibilities, title and the like, (ii) obtaining beneficial interest of any equity interest in the Acquiror on terms and conditions substantially equivalent to those obtained in the Transaction
by all other shareholders of the Company or (iii) the party’s interests in any tax-qualified defined benefit or defined contribution pension or retirement plan in which such party or any Family
Member is a participant or beneficiary. 

  

	 	ii.	 “Merger” means a merger, share exchange, consolidation or similar business consolidation under
applicable law. 

  

	 	iii.	 “Participant’s Affiliates” at any time consist of any entity in which the Participant and/or
members of the Participant’s Family Members then own, directly or beneficially, or have the option or right to acquire, whether or not vested, greater than 10% of such entity’s equity interests, and all then current directors and Executive
Officers of the Company who are members of any group that also includes the Participant, a Family Member and/or any such entity in which the members have agreed to act together for the purpose of participating in the Transaction.

	 	iv.	 “Person” shall have the meaning given in Section 3(a)(9) of the Act, as modified and used in
Sections 13(d) and 14(d) thereof, except that such term shall not include (i) the Company or any of its Subsidiaries, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) a
corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions and with substantially the same voting rights as their ownership and voting rights with respect to the Company.

  

	14.	 Performance-Based Awards. 

 

	 	14.1	 Grandfathered Awards. In the sole discretion of the Committee, any Grandfathered Awards (as
defined below) granted under the Plan may be administered in a manner such that the Award qualifies for the performance-based compensation exemption of Section 162(m) of the Code (each, a “Performance-Based Award”). Notwithstanding
any other provision of the Plan and except as determined by the Committee, any Grandfathered Award which is intended to qualify as a Performance-Based Award shall be subject to any additional limitations imposed under Section 162(m) of the Code
that are requirements for qualification as a Grandfathered Award. A “Grandfathered Award” means an Award which is provided pursuant to a written binding contract in effect on November 2, 2017, and which was not modified in any
material respect on or after November 2, 2017, within the meaning of Section 13601(e)(2) of P.L. 115-97, as may be amended from time to time (including any rules and regulations promulgated
thereunder). 

  

	 	14.2	 Modification of Performance-Based Awards. Subject to Section 12, with respect to any
Performance-Based Awards, the Committee shall not revise any performance goal thereunder or increase the amount of compensation payable thereunder upon the attainment of such performance goal (in accordance with the requirements of
Section 162(m) of the Code and the regulations thereunder). Notwithstanding the preceding sentence, (i) the Committee may reduce or eliminate the number of shares of Common Stock or cash granted or the number of shares of Common Stock
vested upon the attainment of such performance goal, and (ii) the Committee, in its discretion, may measure performance against performance goals under a Performance-Based Award by taking one or more of the following actions: (a) excluding
each of the following items: (i) events of an “unusual nature” or of a type that indicates “infrequency of occurrence”, both as described in Accounting Standards Codification Topic
225-20 or any successor pronouncement thereto (as 

	 	
reported in the Corporation’s financial statements for the Performance Cycle), (ii) exchange rate effects, as applicable, for non-U.S. dollar
denominated operating earnings, (iii) the effects to any statutory adjustments to corporate tax rates, (iv) the impact of discontinued operations, (v) losses from discontinued operations, (vi) restatements and other unplanned
special charges such as acquisitions, acquisition expenses (including, without limitation, expenses relating to goodwill and other intangible assets), (vi) divestitures, (vii) stock offerings, (viii) stock repurchases, (ix) strategic
loan loss provisions and (b) not adjusting for changes in accounting principles; provided that any such action with respect to a Performance-Based Award must be taken by the Committee within the first ninety (90) days applicable to the
Performance Cycle or such later time as may be permitted under Section 162(m) of the Code or as would not cause any deduction arising from such Award to be disallowed under Section 162(m) of the Code. 

 

	15.	 Withholding. 

 

	 	15.1	 Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require
a Participant to remit to the Company, the minimum statutory amount to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Plan
prior to making any payments hereunder. 

  

	 	15.2	 Share Withholding. With respect to withholding required upon the exercise of Options or Stock
Appreciation Rights, upon the lapse of restrictions on Restricted Shares and Restricted Stock Units, or upon the achievement of performance goals related to Performance Share Awards, or any other taxable event arising as a result of an Award granted
hereunder, Participants may elect, subject to the approval of the Committee, to satisfy the withholding requirement, in whole or in part, by having the Company withhold Shares having a Fair Market Value on the date the tax is to be determined equal
to the minimum statutory total tax that could be imposed on the transaction. All such elections shall be irrevocable, made in writing or electronically, and signed or acknowledged electronically by the Participant, and shall be subject to any
restrictions or limitations that the Committee, in its sole discretion, deems appropriate. 

  

	16.	 Certain Terminations of Employment, Hardship and Approved Leaves of Absence. Notwithstanding any
other provision of the Plan to the contrary, in the event of a Participant’s termination of employment (including by reason of death, disability or retirement) or in the event of hardship or other special circumstances, the Committee may in its
sole discretion take any action that it deems to be equitable under the circumstances or in the best interests of the Company, including, without limitation, waiving or modifying any limitation or requirement with respect to any Award under

	 	
the Plan. The Committee shall have the discretion to determine whether and to what extent the vesting of Awards shall be tolled during any leave of absence, paid or unpaid; provided however, that
in the event of military leave, vesting shall toll during any unpaid portion of such leave, provided that, upon a Participant’s returning from military leave (under conditions that would entitle him or her to protection upon such return under
the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to the Award to the same extent as would have applied had the Participant continued to provide services to the Company throughout the
leave on the same terms as he or she was providing services immediately prior to such leave. Any actions taken by the Committee shall be taken consistent with the requirements of Section 409A of the Code and, with respect to Performance-Based
Awards, Section 162(m) of the Code. 

  

	17.	 Authorization of Sub-Plans. The Committee may from time
to time establish one or more sub-plans under the Plan for purposes of satisfying applicable blue sky, securities, and/or tax laws of various jurisdictions. The Committee shall establish such sub-plans by adopting supplements to the Plan containing (a) such limitations as the Committee deems necessary or desirable, and (b) such additional terms and conditions not otherwise inconsistent with the
Plan as the Committee shall deem necessary or desirable. All sub-plans adopted by the Committee shall be deemed to be part of the Plan, but each sub-plan shall apply
only to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any sub-plans to Participants in any jurisdiction which is not the subject of such sub-plan. 

  

	18.	 Amendments and Other Matters. 

 

	 	18.1	 Plan Amendments. The Board may amend, suspend or terminate the Plan or the Committee’s
authority to grant Awards under the Plan at any time. Notwithstanding the foregoing, no amendments shall be effective without approval of the Company’s stockholders if (a) stockholder approval of the amendment is then required pursuant to
the Code, the rules of the primary stock exchange or stock market on which the Shares are then traded, applicable U.S. state corporate laws or regulations, applicable U.S. federal laws or regulations, and the applicable laws of any foreign country
or jurisdiction where Awards are, or shall be, granted under the Plan, or (b) such amendment would (i) modify Section 18.4, (ii) materially increase benefits accruing to Participants, (iii) increase the aggregate number of Shares
issued or issuable under the Plan, (iv) increase any limitation set forth on the number of Shares which may be issued or the aggregate value of Awards or the per-person limits under Section 3 except
as provided in Section 12, (v) modify the eligibility requirements for Participants in the Plan, or (vi) reduce the minimum Option Price and Base Price used to determine the Spread as set forth in Sections 5 and 6, respectively.
Notwithstanding any other provision of the Plan to the contrary, except as provided in Section 18.8, no termination, suspension or amendment of the Plan may adversely affect any outstanding Award without the consent of the affected Participant.

	 	18.2	 Award Deferrals. The Committee may permit Participants to elect to defer the issuance of Shares
or the settlement of Awards in cash under the Plan pursuant to such rules, procedures or programs as it may establish for purposes of the Plan. However, any Award deferrals which the Committee permits must comply with the provisions of
Section 22 and the requirements of Section 409A of the Code. 

  

	 	18.3	 Conditional Awards. The Committee may condition the grant of any award or combination of Awards
under the Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or any Affiliate to the Participant, provided that any such grant must comply with the
provisions of Section 22 and the requirements of Section 409A of the Code. 

  

	 	18.4	 Repricing Prohibited. The terms of outstanding Awards may not be amended to reduce the Option
Price of outstanding Options or Base Price of outstanding Stock Appreciation Rights or cancel outstanding Options or Stock Appreciation Rights in exchange for cash, other Awards or Options or Stock Appreciation Rights with an Option Price or Base
Price that is less than the Option Price or Base Price of the original Options or Stock Appreciation Rights, and the Committee may not take any other action that is considered a “repricing” for purposes of the stockholder approval rules of
the applicable securities exchange or inter-dealer quotation system on which Shares are listed or quoted, without stockholder approval, provided that nothing herein shall prevent the Committee from taking any action provided for in Section 12
above. 

  

	 	18.5	 No Employment Rights. Nothing in the Plan or an Award Agreement shall interfere with or limit in
any way the right of the Company, its Affiliates, and/or its Subsidiaries to terminate any Participant’s employment or service on the Board or to the Company at any time or for any reason not prohibited by law, nor confer upon any Participant
any right to continue his employment or service as a director for any specified period of time. Neither an Award nor any benefits arising under the Plan shall constitute an employment contract with the Company, its Affiliates, and/or its
Subsidiaries and, accordingly, subject to Section 18.1, the Plan and the benefits hereunder may be terminated at any time in the sole and exclusive discretion of the Committee without giving rise to any liability on the part of the Company, its
Affiliates, and/or its Subsidiaries. 

  

	 	18.6	 Tax Qualification. To the extent that any provision of the Plan would prevent any Award that was
intended to qualify under particular provisions of the 

	 	
Code from so qualifying, such provision of the Plan shall be null and void with respect to such Award, provided that such provision shall remain in effect with respect to other Awards, and there
shall be no further effect on any provision of the Plan. 

  

	 	18.7	 Leave of Absence or Transfer. A transfer between the Company and any Affiliate or between
Affiliates, or a leave of absence duly authorized by the Company, shall not be deemed to be a termination of employment. Periods of time while on a duly authorized leave of absence shall be disregarded for purposes of determining whether a
Participant has satisfied a Restricted Period or Performance Cycle under an Award. 

  

	 	18.8	 Amendments to Comply with Laws, Regulations or Rules. Notwithstanding any other provision of the
Plan or any Award Agreement to the contrary, in its sole and absolute discretion and without the consent of any Participant, the Board may amend the Plan, and the Committee may amend any Award Agreement, to take effect retroactively or otherwise as
it deems necessary or advisable for the purpose of conforming the Plan or such Award Agreement to any present or future law, regulation or rule applicable to the Plan, including, but not limited to, Section 409A of the Code.

  

	 	18.9	 Tolling. In the event a Participant is prevented from exercising an Option or the Company is
unable to settle an Award due to either any trading restrictions applicable to the Company’s Shares, the Participant’s physical infirmity or administrative error by the Company relied upon and not caused by the Participant, then unless
otherwise determined by the Committee, the length of time applicable to any such restriction, condition or event shall toll any exercise period (i) until such restriction lapses, (ii) until the Participant (or his representative) is able
to exercise the Award or (iii) until such error is corrected, as applicable. 

  

	 	18.10	 No Duty to Inform Regarding Exercise Rights. Neither the Company, any Affiliate, the Committee
nor the Board shall have any duty to inform a Participant of the pending expiration of the period in which a Stock Appreciation right may be exercised or in which an Option may be exercised. 

 

	19.	 Issuance of Shares; Fractional Shares. 

 

	 	19.1	 Form for Issuing Shares; Legends. Shares may be issued on a certificated or uncertificated basis.
Shares may include any legend which the Committee deems appropriate to reflect any restrictions on transfer of such Shares. 

  

	 	19.2	 Delivery of Title. The Company shall have no obligation to issue or deliver evidence of title for
Shares issued under the Plan prior to: (i) obtaining any approvals from governmental agencies that the Company determines are 

	 	
necessary or advisable; and (ii) completing any registration or other qualification of the Shares under any applicable national or foreign law or ruling of any governmental body that the
Company determines to be necessary or advisable. 

  

	 	19.3	 Inability to Obtain Authority. The inability of the Company to obtain authority from any
regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or
sell such Shares as to which such requisite authority shall not have been obtained. 

  

	 	19.4	 Investment Representations. The Committee may require any individual receiving Shares pursuant to
an Award under the Plan to represent and warrant in writing that the individual is acquiring the Shares for investment and without any present intention to sell or distribute such Shares, 

 

	 	19.5	 Fractional Shares. The Company shall not be required to issue any fractional Shares pursuant to
the Plan. The Committee may provide for the elimination of fractions or for the settlement thereof in cash. 

  

	20.	 Limitations Period. Any person who believes he or she is being denied any benefit or right under
the Plan may file a written claim with the Committee. Any claim must be delivered to the Committee within forty-five (45) days of the specific event giving rise to the claim. Untimely claims will not be processed and shall be deemed denied. The
Committee, or its designated agent, will notify the Participant of its decision in writing as soon as administratively practicable. Claims not responded to by the Committee in writing within ninety (90) days of the date the written claim is
delivered to the Committee shall be deemed denied. The Committee’s decision shall be final, conclusive and binding on all persons. No lawsuit relating to the Plan may be filed before a written claim is filed with the Committee and is denied or
deemed denied, and any lawsuit must be filed within one year of such denial or deemed denial or be forever barred. The venue for any lawsuit shall be Charlotte, North Carolina. 

 

	21.	 Governing Law. The validity, construction and effect of the Plan and any Award hereunder will be
determined in accordance with the State of Delaware except to the extent governed by applicable federal law. 

  

	22.	 Compliance with Section 409A. 

 

	 	22.1	 In General. The Plan is intended to be administered in a manner consistent with the requirements,
where applicable, of Section 409A. For avoidance of doubt, Stock Options and Stock Appreciation Rights are intended to qualify for the stock rights exemptions from Section 409A. Where reasonably possible and practicable, the Plan shall be
administered in a manner to avoid 

	 	
the imposition on Participants of immediate tax recognition and additional taxes pursuant to such Section 409A. Notwithstanding the foregoing, neither the Company nor the Committee shall
have any liability to any person in the event Section 409A applies to any such Award in a manner that results in adverse tax consequences for the Participant or any of his or her transferees. 

 

	 	22.2	 Elective Deferrals. No elective deferrals or re-deferrals
other than in regard to Restricted Stock Units are permitted under the Plan. 

  

	 	22.3	 Applicable Requirements. To the extent any of the Awards granted under the Plan are deemed
“deferred compensation” and hence subject to Section 409A, the following rules shall apply to such Awards: 

  

	 	(a)	 Mandatory Deferrals. If the Company decides that the payment of compensation under the Plan shall
be deferred within the meaning of Section 409A, then, except as provided under Treas. Reg. Section 1.409A-1(b)(4)(ii), on granting of the Award to which such compensation payment relates, the Company
shall specify the date(s) at which such compensation will be paid in the Award Agreement. 

  

	 	(b)	 Initial Deferral Elections. For Awards of RSUs where the Committee provides the opportunity to
elect the timing and form of the payment of the underlying Shares at some future time once any requirements have been satisfied, the Participant must make his or her initial deferral election for such Award in accordance with the requirements of
Section 409A, i.e., within thirty (30) days of first becoming eligible to receive such award or prior to the start of the year in which the Award is granted to the Participant, in each case pursuant to the requirements of Section 409A
and Treas. Reg. Section 1.409A-2. 

  

	 	(c)	 Subsequent Deferral Elections. To the extent the Company or Committee decides to permit
compensation subject to Section 409A to be re-deferred pursuant to Treas. Reg. Section 1.409A-2(b), then the following conditions must be met: (i) such
election will not take effect until at least 12 months after the date on which it is made; (ii) in the case of an election not related to a payment on account of disability, death or an unforeseeable emergency, the payment with respect to which
such election is made must be deferred for a period of not less than five years from the date such payment would otherwise have been paid; and (iii) any election related to a payment at a specified time or pursuant to a fixed schedule (within
the meaning of Treas. Reg. Section 1.409A-3(a)(4)) must be made not less than 12 months before the date the payment is scheduled to be paid. 

	 	(d)	 Timing of Payments. Payment(s) of compensation that is subject to Section 409A shall only be
made upon an event or at a time set forth in Treas. Reg. Section 1.409A-3, i.e., the Participant’s separation from service, the Participant’s becoming disabled, the Participant’s death, at
a time or a fixed schedule specified in the Plan or an Award Agreement, a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the assets of the Company, or the occurrence of an unforeseeable
emergency. 

  

	 	(e)	 Certain Delayed Payments. Notwithstanding the foregoing, to the extent an amount was intended to
be paid such that it would have qualified as a short-term deferral under Section 409A and the applicable regulations, then such payment is or could be delayed if the requirements of Treas. Reg.
1.409A-1(b)(4)(ii) are met. 

  

	 	(f)	 Acceleration of Payment. Any payment made under the Plan to which Section 409A applies may
not be accelerated, except in accordance with Treas. Reg. 1.409A-3(j)(4). 

  

	 	(g)	 Payments upon a Change in Control. Notwithstanding any provision of the Plan to the contrary, to
the extent an Award subject to Section 409A shall be deemed to be vested or restrictions lapse, expire or terminate upon the occurrence of a Change in Control and such Change in Control does not constitute a “change in the ownership or
effective control” or a “change in the ownership of a substantial portion of the assets” of the Company within the meaning of Section 409A (a)(2)(A)(v), then even though such Award may be deemed to be vested or restrictions
lapse, expire or terminate upon the occurrence of the Change in Control or any other provision of the Plan, payment will be made, to the extent necessary to comply with the provisions of Section 409A, to the Participant on the earliest of
(i) the Participant’s “separation from service” with the Company (determined in accordance with Section 409A), (ii) the date payment otherwise would have been made pursuant to the regular payment terms of the Award in the
absence of any provisions in the Plan to the contrary (provided such date is permissible under Section 409A) or (iii) the Participant’s death. 

  

	 	(h)	 Payments to Specified Employees. Payments due to a Participant who is a “specified
employee” within the meaning of Section 409A on account of the Participant’s “separation from service” with the Company (determined in accordance with Section 409A) shall be made on the date that is six months after the
date of the Participant’s separation from service or, if earlier, the Participant’s date of death. 

	 	22.4	 Determining “Controlled Group”. In order to determine for purposes of Section 409A
whether a Participant or eligible individual is employed by a member of the Company’s controlled group of corporations under Section 414(b) of the Code (or by a member of a group of trades or businesses under common control with the
Company under Section 414(c) of the Code) and, therefore, whether the Shares that are or have been purchased by or awarded under the Plan to the Participant are shares of “service recipient” stock within the meaning of
Section 409A, a Participant or eligible employee of Premier Healthcare Alliance, L.P. shall be considered employed by the Company’s controlled group (or by a member of a group of trades or businesses under common control with the Company,
as applicable). 

  

	23.	 Transferability. 

 

	 	23.1	 Transfer Restrictions. Except as provided in Sections 23.2 and 23.4, no Award granted under the
Plan shall be transferable by a Participant other than upon death by will or the laws of descent and distribution, and Options and Stock Appreciation Rights shall be exercisable during a Participant’s lifetime only by the Participant or, in the
event of the Participant’s legal incapacity, by his guardian or legal representative acting in a fiduciary capacity on behalf of the Participant under state law. Any attempt to transfer an Award in violation of the Plan shall render such Award
null and void. 

  

	 	23.2	 Limited Transfer Rights. The Committee may expressly provide in an Award Agreement that a
Participant may transfer such Award (other than an Incentive Stock Option), in whole or in part, to a Family Member, a trust for the exclusive benefit of the Participant and Family Members, a partnership or other entity in which all the beneficial
owners are the Participant and Family Members, or any other entity affiliated with the Participant that may be approved by the Committee. Subsequent transfers of Awards shall be prohibited except in accordance with this Section 23.2. All terms
and conditions of the Award, including provisions relating to the termination of the Participant’s covered employment or service shall continue to apply following a transfer made in accordance with this Section 23.2. 

 

	 	23.3	 Additional Restrictions on Transfer. Any Award made under the Plan may provide that all or any
part of the Shares that are to be issued or transferred by the Company upon exercise, vesting or settlement shall be subject to further restrictions upon transfer. 

 

	 	23.4	 Domestic Relations Orders. Notwithstanding the foregoing provisions of this Section 23, any
Award made under the Plan may be transferred as necessary to fulfill any domestic relations order as defined in Section 414(p)(1)(B) of the Code. 

	24.	 Forfeiture, Recoupment and Clawback. Without limiting in any way the generality of
the Committee’s power to specify any terms and conditions of an Award consistent with law, and for greater clarity, the Committee may specify in an Award Agreement that the Participant’s rights, payments and benefits with respect to an
Award, including any payment of Shares received upon exercise or in satisfaction of an Award under the Plan shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events, in addition to any
otherwise applicable vesting or performance conditions, without limit as to time. Such events shall include, but not be limited to, failure to accept the terms of the Award Agreement, termination of service under certain or all circumstances,
violation of material Company policies, material misstatement of financial or other material information about the Company, fraud, misconduct, breach of noncompetition, confidentiality, nonsolicitation, noninterference, corporate property
protection, or other agreements that may apply to the Participant, or other conduct by the Participant that the Committee determines is detrimental to the business or reputation of the Company and its Affiliates, including facts and circumstances
discovered after termination of service. Awards granted under the Plan shall be subject to any compensation recovery policy or minimum stock holding period requirement as may be adopted or amended by the Company from time to time. All Awards
(including any proceeds, gains or other economic benefit actually or constructively received by a Participant upon any receipt or exercise of any Award or upon the receipt or resale of any Shares underlying the Award) shall be subject to the
provisions of any clawback policy implemented by the Company, including, without limitation, any clawback policy adopted to comply with the requirements of applicable law, including without limitation the Dodd-Frank Wall Street Reform and Consumer
Protection Act and any rules promulgated thereunder, to the extent set forth in such clawback policy and/or in the applicable Award Agreement. 

  

	25.	 No Constraint on Corporate Action. Nothing in the Plan shall be construed to: (i) limit,
impair, or otherwise affect the Company’s or an Affiliate’s or a Subsidiary’s right or power to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure, or to merge or consolidate, or
dissolve, liquidate, sell, or transfer all or any part of its business or assets; or, (ii) limit the right or power of the Company or an Affiliate or a Subsidiary to take any action which such entity deems to be necessary or appropriate.

  

	26.	 Effect of Disposition of Facility or Operating Unit. If the Company or any of its Affiliates
closes or disposes of the facility at which a Participant is located or the Company or any of its Affiliates diminish or eliminate ownership interests in any operating unit of the Company or any of its Affiliates so that such operating unit ceases
to be majority owned by the Company or any of its Affiliates then, with respect to Awards held by Participants who, subsequent to such event, will not be Employees, the Committee may, to the extent consistent with Section 409A (if applicable),
take any of the actions described in Section 13.1 with respect to a Change 

	 	
in Control. If the Committee takes no special action with respect to any disposition of a facility or an operating unit, then the Participant shall be deemed to have terminated his or her
employment with the Company and its Subsidiaries and Affiliates and the terms and conditions of the Award Agreement and the other terms and conditions of the Plan shall control. 

 

	27.	 Indemnification. Subject to requirements of applicable state law, each individual who is or shall
have been a member of the Board, or a Committee appointed by the Board, or an officer of the Company to whom authority was delegated in accordance with Section 4, shall be indemnified and held harmless by the Company against and from any loss,
cost, liability, or expense that may be imposed upon or reasonably incurred by him in connection with or resulting from any claim, action, suit, or proceeding to which he may be a party or in which he or she may be involved by reason of any action
taken or failure to act under the Plan and against and from any and all amounts paid by him in settlement thereof, with the Company’s approval, or paid by him in satisfaction of any judgment in any such action, suit, or proceeding against him,
provided he shall give the Company an opportunity, at its own expense, to handle and defend the same before he undertakes to handle and defend it on his own behalf, unless such loss, cost, liability, or expense is a result of his own willful
misconduct or except as expressly provided by statute. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such individuals may be entitled under the Company’s Certificate of
Incorporation or by-laws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 

 

	28.	 Nonexclusivity of the Plan. The adoption of the Plan shall not be construed as
creating any limitations on the power of the Board or Committee to adopt such other compensation arrangements as it may deem desirable for any Participant. 

  

	29.	 Miscellaneous. 

 

	 	29.1	 Gender and Number. Except where otherwise indicated by the context, any masculine term used
herein also shall include the feminine, the plural shall include the singular, and the singular shall include the plural. 

  

	 	29.2	 Severability. In the event any provision of the Plan shall be held illegal or invalid for any
reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included. 

 

	 	29.3	 Requirements of Law. The granting of Awards and the issuance of Shares under this Plan shall be
subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. 

	 	29.4	 Successors. All obligations of the Company under the Plan with respect to Awards granted
hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the
Company. 

  

	 	29.5	 Payment Following a Participant’s Death. Any remaining vested
rights or benefits under the Plan upon a Participant’s death shall be paid or provided to the Participant’s legal spouse or, if no such spouse survives the Participant, to the Participant’s estate. 

 

	 	29.6	 Rights as a Shareholder. Except as otherwise provided herein, a Participant shall have none of
the rights of a shareholder with respect to Shares covered by any Award until the Participant becomes the record holder of such Shares. 

Original Effective Date: September 24, 2013 
 Amended and
Restated Effective Date: December 4, 2015 
 Further Amended Effective Date: August 11, 2016 

Further Amended and Restated Effective Date: December 1, 2017 

Further Amended and Restated Effective Date: December 7, 2018EXCHANGE
AGREEMENT

 

THIS
EXCHANGE AGREEMENT (the “Agreement”) is as of November 30, 2018, by and among Endonovo Therapeutics, Inc.
a Delaware corporation (the “Company”), and Eagle Equities, LLC (the “Holder”).

 

WHEREAS,
the Holder beneficially owns and holds a certain Secured Promissory Note, as set forth on Exhibit A hereto (the “Securities”);
and

 

WHEREAS,
the Holder desires to exchange (the “Exchange”) the Securities for a new Secured Convertible Promissory Note
(the “Exchange Securities”) of the Company as set forth and memorialized on Exhibit B hereto, and the
Company desires to issue the Exchange Securities in exchange for the Securities, all on the terms and conditions set forth in
this Agreement in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended
(the “Securities Act”).

 

NOW,
THEREFORE, in consideration of the terms and conditions contained herein, and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the Company and the Holder hereby agree as follows:

 

Section
1. Exchange. Subject to and upon the terms and conditions set forth in this Agreement, the Holder agrees to surrender to
the Company the Securities and, in exchange therefore, the Company shall issue to the Holder the Exchange Securities.

 

1.1
Closing. On the Closing Date (as defined below), the Company will issue and deliver (or cause to be issued and delivered)
the Exchange Securities to the Holder, or in the name of a custodian or nominee of the Holder, or as otherwise requested by the
Holder in writing, and the Holder will surrender to the Company the Securities. The closing of the Exchange shall occur on December
5, 2018 or as soon thereafter as the parties may mutually agree in writing (the “Closing Date”), subject to
the provisions of Section 4 and Section 5 herein.

 

1.2
Section 3(a)(9). Assuming the accuracy of the representations and warranties of each of the Company and the Holder set
forth in Sections 2 and 3 of this Agreement, the parties acknowledge and agree that the purpose of such representations and warranties
is, among other things, to ensure that the Exchange qualifies as an exchange of securities under Section 3(a)(9) of the Securities
Act.

 

Section
2. Representations and Warranties of the Company. The Company represents and warrants to the Holder that:

 

    	 

    	 

    

 

2.1
Organization and Qualification. The Company is an entity duly incorporated or otherwise organized, validly existing and
in good standing under the laws of the State of Delaware, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. The Company is not in violation or default of any of the provisions
of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company is
duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which
the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be
so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse
effect on the legality, validity or enforceability of this Agreement or any documents executed in connection herewith (the “Transaction
Documents”), (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or
seeking to revoke, limit or curtail such power and authority or qualification.

 

2.2
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action
on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders
in connection herewith or therewith other than in connection with the Required Approvals (as defined below). This Agreement and
each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company
and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except: as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’
rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

2.3
Issuance of Exchange Securities. The issuance of the Exchange Securities is duly authorized and, upon issuance in accordance
with the terms hereof, the Exchange Securities shall be validly issued, fully paid and nonassessable. The shares of Common Stock
issued upon conversion of the Exchange Securities, when issued and delivered in accordance with the terms of the Exchange Securities,
will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens (as defined below) imposed by the
Company, other than restrictions on transfer under applicable state and federal securities laws. Upon issuance in accordance herewith,
the issuance by the Company of the Exchange Securities is exempt from the registration requirements of the Securities Act under
Section 3(a)(9) of the Securities Act and all of the shares of Common Stock issuable upon conversion of the Exchange Securities
will be freely transferable and freely tradable by the Holder without restriction pursuant to Rule 144 of the Securities Act,
assuming the Holder is not an Affiliate and the holding period requirements of Rule 144 have been met. The shares of Common Stock
issuable upon conversion of the Exchange Securities shall not bear any restrictive or other legends or notations.

 

    	 

    	 

    

 

2.4
No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance of the Exchange Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents; (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any options, contracts,
agreements, liens, security interests, or other encumbrances (“Liens”) upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected; or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by
which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

 

2.5
Acknowledgment Regarding the Exchange. The Company acknowledges and agrees that the Holder is acting solely in the capacity
of an arm’s length third party with respect to this Agreement and the transactions contemplated hereby. The Company further
acknowledges the Holder is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect
to this Agreement and the transactions contemplated hereby, and any advice given by the Holder or any of their representatives
or agents in connection with this Agreement is merely incidental to the Exchange.

 

2.6
No Commission; No Other Consideration. The Company has not paid or given, and has not agreed to pay or give, directly or
indirectly, any commission or other remuneration for soliciting the Exchange. The Exchange Securities are being issued exclusively
for the exchange of the Securities and no other consideration has or will be paid for the Exchange Securities.

 

2.7
3(a)(9) Representation. The Company has not, nor has any person acting on its behalf, directly or indirectly made any offers
or sales of any security or solicited any offers to buy any security under circumstances that would cause the Exchange and the
issuance of the Exchange Securities pursuant to this Agreement to be integrated with prior offerings by the Company for purposes
of the Securities Act which would prevent the Company from delivering the Exchange Securities to the Holder pursuant to Section
3(a)(9) of the Securities Act, nor will the Company take any action or steps that would cause the Exchange, issuance and delivery
of the Exchange Securities to be integrated with other offerings to the effect that the delivery of the Exchange Securities to
the Holder would be seen not to be exempt pursuant to Section 3(a)(9) of the Securities Act.

 

    	 

    	 

    

 

2.8
No Third-party Advisors. Other than legal counsel, the Company has not engaged any third parties to assist in the solicitation
with respect to the Exchange.

 

2.9
SEC Reports: Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act of 1934, as amended (the “Exchange
Act”), including pursuant to Section 13(a) or 15(d) of the Exchange Act, for the two years preceding the date hereof
(or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC
Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules
and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects
the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit
adjustments.

 

2.10
Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. Except as may
be set forth in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests
of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary
are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

2.11
Filings, Consents and Approvals. the Company is not required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority
or any natural person, firm, partnership, association, corporation, company, trust, business trust or other entity (each, a “Person”)
in connection with the execution, delivery and performance by the Company of the Transaction Documents.

 

2.12
DTC Eligibility. The Company, through its Transfer Agent, currently participates in the DTC Fast Automated Securities Transfer
(FAST) Program and the Common Stock can be transferred electronically to third parties via the DTC Fast Automated Securities Transfer
(FAST) Program.

 

    	 

    	 

    

 

2.13
Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements
included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i)
there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse
Effect; (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued
expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected
in the Company’ s financial statements pursuant to GAAP or disclosed in filings made with the SEC; (iii) the Company has
not altered its method of accounting; and (iv) the Company has not declared or made any dividend or distribution of cash or other
property to its stockholder or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock
and (. The Company does not have pending before the SEC any request for confidential treatment of information. Except for the
issuance of the Exchange Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
businesses, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least
one (1) Trading Day prior to the date that this representation is made.

 

2.14
Litigation. Other than as set forth in the Company’s Annual Report filed on form 1OK, there is no action, suit, inquiry,
notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting
the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”)
which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the
Exchange Securities or could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse
Effect.

 

2.15
Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect.

 

2.16
Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary
under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation
of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any
of its properties is bound (whether or not such default or violation has been waived); (ii) is in violation of any judgment, decree
or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance
or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters,
except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

    	 

    	 

    

 

2.17
Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described
in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material
Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice of
proceedings relating to the revocation or modification of any Material Permit.

 

2.18
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and
the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries,
(ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties and (iii) Liens held by the Holder and a second
priority lien held by the Company’s Series C Preferred Stock. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries
are in compliance.

 

2.19
Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries
are engaged Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue
its business without a significant increase in cost.

 

    	 

    	 

    

 

2.20
Sarbanes-Oxley; Internal Accounting Controls. Except as may be set forth in its reports filed under the Exchange Act, the
Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that
are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the SEC thereunder that are
effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s
general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements
in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed
such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files
or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s
rules and forms. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures
of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange
Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under
the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control
over financial reporting (as such term is defined in the Exchange Act) that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.

 

2.21
Certain Fees. no brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiaries
to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect
to the transactions contemplated by the Transaction Documents .

 

2.22
Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Exchange
Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company”
subject to registration under the Investment Company Act of 1940, as amended.

 

2.23
Registration Rights. Except as disclosed in the SEC Filings, no Person has any right to cause the Company to effect the
registration under the Securities Act of any securities of the Company or any Subsidiaries.

 

2.24
Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating
terminating such registration. Other than as set forth in Schedule 2.27, the Company has not, in the 12 months preceding
the date hereof, received notice from the OTC or any other exchange or quotation service on which the Common Stock is or has been
listed or quoted (the “Trading Market”) to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. Other than as set forth in Schedule 2.27, the Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance
requirements.

 

    	 

    	 

    

 

2.25
Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided the Holder or its agents
or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Holder will rely on the foregoing representation in effecting transactions in securities of
the Company. All of the disclosure furnished by or on behalf of the Company to the Holder regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is
true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in
order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The press
releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were made and when made, not misleading. The Company
acknowledges and agrees that the Holder makes no nor has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 3 hereof

 

2.26
No Integrated Offering. Assuming the accuracy of the Holder’s representations and warranties set forth in Section
3, neither the Company, nor any of its Affiliates, nor any Person acting on their behalf has, directly or indirectly, made any
offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Exchange
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration
of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.

 

2.27
Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and
local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which
it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the
payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of
the Company or of any Subsidiary know of no basis for any such claim.

 

2.28
Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly , used any funds
for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity;
(ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds; (iii) failed to disclose fully any contribution made by the Company or any Subsidiary
(or made by any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any
material respect any provision of the FCPA.

 

    	 

    	 

    

 

2.29
No Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the
Company and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company’s
ability to perform any of its obligations under any of the Transaction Documents.

 

2.30
Acknowledgment Regarding Holder’s Exchange of Securities. The Company acknowledges and agrees that the Holder is
acting solely in the capacity of an arm’ s length party with respect to the Transaction Documents and the transactions contemplated
thereby.

 

2.31
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of
the Company to facilitate the issuance or resale of any of the Exchange Securities or the shares of Common Stock into which the
Exchange Securities are convertible or exercisable , as applicable, (ii) sold, bid for, purchased, or paid any compensation for
soliciting purchases of, any of the Exchange Securities or the shares of Common Stock into which the Exchange Securities are convertible
or exercisable, as applicable, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase
any other securities of the Company.

 

2.32
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

2.33
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve
System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent
or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

2.34
Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company or any Subsidiary, threatened.

 

    	 

    	 

    

 

2.35
Security Interest. The Security interest being granted to the Holder under the Transaction Documents is a valid
first priority lien on the collateral set forth therein.

 

Section
3. Representations and Warranties of the Holder. The Holder represents and warrants, severally and not jointly, to the
Company that:

 

3.1
Ownership of the Securities. The Holder is the legal and beneficial owner of the Securities. The Holder paid for the Securities,
and has continuously held the Securities since its issuance or purchase. The Holder owns the Securities outright and free and
clear of any options, contracts, agreements, liens, security interests, or other encumbrances.

 

3.2
No Public Sale or Distribution. The Holder is acquiring the Exchange Securities in the ordinary course of business for
its own account and not with a view toward, or for resale in connection with, the public sale or distribution thereof; provided,
however, that by making the representations herein, the Holder does not agree to hold any of the Exchange Securities or the shares
of Common Stock into which such securities are convertible or exercisable, as applicable, for any minimum or other specific term
and reserves the right to dispose of the Exchange Securities and the shares of Common Stock into which such securities are convertible
and exercisable at any time in accordance with an exemption from the registration requirements of the Securities Act and applicable
state securities laws. The Holder does not presently have any agreement or understanding, directly or indirectly, with any person
to distribute, or transfer any interest or grant participation rights in, the Securities or the Exchange Securities.

 

3.3
Accredited Investor and Affiliate Status. The Holder is an “accredited investor” as that term is defined in
Rule 501 of Regulation D under the Securities Act. The Holder is not, and has not been, for a period of at least three months
prior to the date of this Agreement (a) an officer or director of the Company, (b) an “affiliate” of the Company (as
defined in Rule 144) (an “Affiliate”) or (c) a “beneficial owner” of more than 10% of the common
stock (as defined for purposes of Rule 13d-3 of the Exchange Act).

 

3.4
Reliance on Exemptions. The Holder understands that the Exchange is being made in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying in part upon
the truth and accuracy of, and the Holder’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Holder set forth herein in order to determine the availability of such exemptions and the eligibility
of the Holder to complete the Exchange and to acquire the Exchange Securities.

 

    	 

    	 

    

 

3.5
Information. The Holder has been furnished with all materials relating to the business, finances and operations of the
Company and materials relating to the Exchange which have been requested by the Holder. The Holder has been afforded the opportunity
to ask questions of the Company. Neither such inquiries nor any other due diligence investigations conducted by the Holder or
its representatives shall modify, amend or affect the Holder’s right to rely on the Company’s representations and
warranties contained herein. The Holder acknowledges that all of the documents filed by the Company with the SEC under Sections
13(a), 14(a) or 15(d) of the Exchange Act that have been posted on the SEC’s EDGAR site are available to the Holder, and
the Holder has not relied on any statement of the Company not contained in such documents in connection with the Holder’s
decision to enter into this Agreement and the Exchange.

 

3.6
Risk. The Holder understands that its investment in the Exchange Securities involves a high degree of risk. The Holder
is able to bear the risk of an investment in the Exchange Securities including, without limitation, the risk of total loss of
its investment. The Holder has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the Exchange. There is no assurance that the Exchange Securities or any securities into which
the Exchange Securities may convert will continue to be quoted, traded or listed for trading or quotation on the OTCBB or on any
other organized market or quotation system.

 

3.7
No Governmental Review. The Holder understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement in connection with the Exchange or the fairness or
suitability of the investment in the Exchange Securities nor have such authorities passed upon or endorsed the merits of the Exchange
Securities.

 

3.8
Organization; Authorization. The Holder is duly organized, validly existing and in good standing under the laws of its
state of formation and has the requisite organizational power and authority to enter into and perform its obligations under this
Agreement.

 

3.9
Validity: Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Holder
and shall constitute the legal, valid and binding obligations of the Holder enforceable against the Holder in accordance with
its terms. The execution, delivery and performance of this Agreement by the Holder and the consummation by the Holder of the transactions
contemplated hereby (including, without limitation, the irrevocable surrender of the Securities) will not result in a violation
of the organizational documents of the Holder.

 

3.10
Prior Investment Experience. The Holder acknowledges that it has prior investment experience, including investment in securities
of the type being exchanged, including the Securities and the Exchange Securities, and has read all of the documents furnished
or made available by the Company to it and is able to evaluate the merits and risks of such an investment on its behalf, and that
it recognizes the highly speculative nature of this investment.

 

    	 

    	 

    

 

3.11
Tax Consequences. The Holder acknowledges that the Company has made no representation regarding the potential or actual
tax consequences for the Holder which will result from entering into the Agreement and from consummation of the Exchange. The
Holder acknowledges that it bears complete responsibility for obtaining adequate tax advice regarding the Agreement and the Exchange.

 

3.12
No Registration, Review or Approval. The Holder acknowledges, understands and agrees that the Exchange Securities are being
exchanged hereunder pursuant to an exchange offer exemption under Section 3(a)(9) of the Securities Act.

 

Section
4. Conditions Precedent to Obligations of the Company. The obligation of the Company to consummate the transactions contemplated
by this Agreement is subject to the satisfaction of each of the following conditions, provided that these conditions are for the
Company’s sole benefit and may be waived by the Company at any time in its sole discretion by providing the Holder with
prior written notice thereof:

 

4.1
Delivery. The Holder shall have delivered to the Company the Securities.

 

4.2
No Prohibition. No order of any court, arbitrator, or governmental or regulatory authority shall be in effect which purports
to enjoin or restrain any of the transactions contemplated by this Agreement; and

 

4.3
Representations. The accuracy in all material respects when made and on the applicable Closing Date of the representations
and warranties of the Holder contained herein (unless as of a specific date therein);

 

Section
5. Conditions Precedent to Obligations of the Holder. The obligation of the Holder to consummate the transactions contemplated
by this Agreement is subject to the satisfaction of each of the following conditions, provided that these conditions are for the
Holder’s sole benefit and may be waived by the Holder at any time in its sole discretion by providing the Company with prior
written notice thereof:

 

5.1
No order of any court, arbitrator, or governmental or regulatory authority shall be in effect which purports to enjoin or restrain
any of the transactions contemplated by this Agreement;

 

5.2
the representations and warranties of the Company (i) shall be true and correct in all material respects when made and on the
applicable Closing Date (unless as of a specific date therein) for such representations and warranties contained herein that are
not qualified by “materiality” or “Material Adverse Effect” and (ii) shall be true and correct when made
and on the applicable Closing Date (unless as of specific date therein) for such representations and warranties contained herein
that are qualified by “materiality” or “Material Adverse Effect”;

 

    	 

    	 

    

 

5.3
all obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall
have been performed; and

 

5.4
from the date hereof to the relevant Closing Date, trading in the Company’s common stock shall not have been suspended by
the SEC or any Trading Market and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited.

 

5.5
Section 6. No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

Section
6. Entire Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Holder,
the Company, their affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement
and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered herein
and therein and, except as specifically set forth herein or therein, neither the Company nor the Holder makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be amended other than by an
instrument in writing signed by the Company and the Holder. No provision hereof may be waived other than by an instrument in writing
signed by the party against whom enforcement is sought.

 

Section
7. Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of
this Agreement must be in writing and will be deemed to have been delivered: (a) upon receipt, when delivered personally; (b)
upon receipt, when sent by email (provided confirmation of transmission is mechanically or electronically generated and kept on
file by the sending party); or (c) one calendar day (excluding Saturdays, Sundays, and national banking holidays) after deposit
with an overnight courier service, in each case properly addressed to the party to receive the same.

 

The
addresses and email addresses numbers for such communications shall be:

 

If
to the Company:

 

Endonovo
Therapeutics, Inc. 

6320
Canoga Avenue 15th Floor, Woodland Hills, CA 91367

Alan
Collier, CEO

acollier@endonovo.com

 

    	 

    	 

    

 

If
to the Holder:

 

Eagle
Equities, LLC

91
Shelton Ave - Suite 107

New
Haven, CT 06511

ATTN.:
Yakov Borenstien, Manager yanky@ucapllc.com

 

or
to such other address and/or email address and/or to the attention of such other person as the recipient party has specified by
written notice given to each other party five (5) days prior to the effectiveness of such change.

 

Section
8. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including any purchasers of the Exchange Securities. The Holder may assign some or all of its rights hereunder
without the consent of the Company, in which event such assignee shall be deemed to be the Holder hereunder with respect to such
assigned rights.

 

Section
9. No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

Section
10. Survival of Representations. The representations and warranties of the Company and the Holder contained in Sections
2 and 3, respectively, will survive the closing of the transactions contemplated by this Agreement.

 

Section
11. Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

[Signature
Page Follows]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Exchange Agreement as of the date first written above.

 

	ENDONOVO
    THERAPEUTICS, INC.	 
	 	 	 
	By	/s/
    Alan Collier 	 
	 	Alan
    Collier, CEO	 
	 	 	 
	EAGLE
    EQUITIES, LLC	 
	 	 	 
	By	/s/
    Yakov Borenstein 	 
	 	Yakov
    Borenstein, Manager	 

 

    	 

    	 

    

 

EXHIBIT
A

 

    	 

    	 

    

 

EXHIBIT
B

 

Form
of and Convertible Secured Promissory Note

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]